New combo therapy shows promise in kidney cancer fight
Disease control
Ongoing
This study tested two immunotherapy drugs, nivolumab and ipilimumab, in 85 adults with advanced kidney cancer that could not be removed by surgery. The goal was to see if stopping nivolumab early in those who responded well, or adding ipilimumab in those who did not, could better…
Phase: PHASE2 • Sponsor: Toni Choueiri, MD • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC